Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Tempo Intimedia Tbk. (TMPO) Price & Performance

UBC Medical Indonesia Tbk.Trade
Tempo Intimedia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Tempo Intimedia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Tempo Intimedia Tbk. trades at Rp104 (market cap 109.01B, 5.63M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5.3× Tempo Intimedia Tbk.'s market cap, and Tempo Intimedia Tbk. is more actively traded (5.63M versus 3.48M). Which is the better fit depends on your goals.

LABSTMPO
Market Cap
576.7B109.01B
Volume
3.48M5.63M
Lot
34.82K56.35K
Turnover
522.79M582.8M
Average Price
150.13103.43
Value
522.79M582.8M
Indicative Equilibrium Price
148104
Indicative Equilibrium Volume
3501.1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
TMPO
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Tempo Intimedia Tbk.

PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.

Read more on TMPO